Convatec CEO to take medical leave of absence

Convatec’s chief executive Karim Bitar is to take a medical leave of absence from the company, the medical products and technologies group announced on Monday.

  • Convatec Group
  • 04 August 2025 07:24:15
ConvaTec Group

Source: Sharecast

Chief financial officer Jonny Mason will step in to become interim CEO, and be replaced by group financial controller Fiona Ryder, while the company waits for Bitar’s return.

Bitar, who has been CEO at Convatec since 2019, is the former boss of animal genetics company Genus, and prior to that spent 15 years working for American pharma giant Eli Lilly.

In Convatec's interim results last week, Batir said the company was "well-positioned to deliver our medium-term targets" after growing revenues and operating profits by 6% and 20.1% in the first half, respectively.

Batir said the growth targets, which include double-digit compound annual growth in EPS and free cash flow to equity, "will be driven by our leading positions in structurally growing markets, strongest-ever innovation pipeline and clear focus on execution excellence by our dedicated team of over 10,000 colleagues worldwide".

Exchange: London Stock Exchange
Sell:
0.00
Buy:
0.00
Change: -18.98 ( -0.18 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2026 Refinitiv, an LSEG business. All rights reserved.